Skip to main content

Table 2 Medication usage with the CARRAnet JDM cohort (N=102)

From: Diagnostic evaluation and medication usage in a cohort of subjects with juvenile dermatomyositis from the CARRAnet registry

  Current use Previous use Never used Missing
All corticosteroids 51 (52.6%) 46 (47.4%) 0 (0.0%) 5
Daily corticosteroids 50 (51.5%) 46 (47.4%) 1 (1.1%) 5
Methotrexate 65 (68.4%) 27 (28.4%) 3 (3.2%) 7
Pulse corticosteroids 4 (4.2%) 48 (50.5%) 43 (45.3%) 7
Hydroxychlorquine 39 (41.1%) 17 (17.9%) 39 (41.1%) 7
Intravenous gammaglobulin 24 (24.5%) 24 (24.5%) 50 (51.0%) 4
Mycophenolate mofetil 13 (13.7%) 5 (5.3%) 77 (81.1%) 7
Cyclosporine A 4 (4.2%) 5 (5.3%) 86 (90.5%) 7
Rituximab 1 (1.0%) 7 (7.1%) 90 (91.8%) 4
Cyclophosphamide 0 (0.0%) 2 (2.1%) 93 (97.9%) 7